WITHDRAWN: A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression

Atale, 2009, Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome, Eur. J. Med. Genet., 52, 23, 10.1016/j.ejmg.2008.10.003 Ballinger, 1992, Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion, Nat. Genet., 1, 11, 10.1038/ng0492-11 Blackwood, 2010, The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells, Biochem. Biophys. Res. Commun., 393, 740, 10.1016/j.bbrc.2010.02.072 Gibson, 1992, 3-Methylglutaconic aciduria associated with Pearson syndrome and respiratory chain defects, J. Pediatr., 121, 940, 10.1016/S0022-3476(05)80348-8 Grady, 2014, Disease progression in patients with single, large-scale mitochondrial DNA deletions, Brain, 137, 323, 10.1093/brain/awt321 Katada, 2013, Mitochondrial DNA with a large-scale deletion causes two distinct mitochondrial disease phenotypes in mice, G3 (Bethesda), 3, 1545, 10.1534/g3.113.007245 Lee, 2007, The neurological evolution of Pearson syndrome: case report and literature review, Eur. J. Paediatr. Neurol., 11, 208, 10.1016/j.ejpn.2006.12.008 Li, 2003, Pearson's syndrome: a rare cause of non-immune hydrops fetalis, Chin. Med. J. Engl., 116, 1952 Malik, 2013, Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction?, Mitochondrion, 13, 481, 10.1016/j.mito.2012.10.011 Manea, 2009, Pearson syndrome in the neonatal period: two case reports and review of the literature, J. Pediatr. Hematol. Oncol., 31, 947, 10.1097/MPH.0b013e3181bbc4ef McShane, 1991, Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA, Am. J. Hum. Genet., 48, 39 Morris, 1997, Pearson's syndrome without marrow involvement, Arch. Dis. Child., 77, 56, 10.1136/adc.77.1.56 Munakata, 2005, Co-existing point mutations of mitochondrial DNA in a patient with a heart abnormality and Pearson syndrome-like symptoms, Am. J. Med. Genet. A, 139a, 162, 10.1002/ajmg.a.31003 Muraki, 1997, The association between haematological manifestation and mtDNA deletions in Pearson syndrome, J. Inherit. Metab. Dis., 20, 697, 10.1023/A:1005378527077 Nicolino, 1997, Identification of a large-scale mitochondrial deoxyribonucleic acid deletion in endocrinopathies and deafness: report of two unrelated cases with diabetes mellitus and adrenal insufficiency, respectively, J. Clin. Endocrinol. Metab., 82, 3063 Odoardi, 2003, Pathogenic role of mtDNA duplications in mitochondrial diseases associated with mtDNA deletions, Am. J. Med. Genet. A, 118a, 247, 10.1002/ajmg.a.20006 Rotig, 1995, Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome, Hum. Mol. Genet., 4, 1327, 10.1093/hmg/4.8.1327 Rotig, 1990, Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy, J. Clin. Investig., 86, 1601, 10.1172/JCI114881 Sadikovic, 2010, Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes, PLoS One, 5, e15687, 10.1371/journal.pone.0015687 Schapira, 2012, Mitochondrial diseases, Lancet, 379, 1825, 10.1016/S0140-6736(11)61305-6 Williams, 2012, Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency, Mol. Genet. Metab., 106, 104, 10.1016/j.ymgme.2012.01.018 Zung, 2004, Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2, J. Clin. Endocrinol. Metab., 89, 5504, 10.1210/jc.2004-1241